|
MAPK14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.975800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.770400E-01 |
| Normal-vs-Stage2 |
4.122000E-01 |
| Normal-vs-Stage3 |
6.692600E-01 |
| Normal-vs-Stage4 |
6.513200E-01 |
| Stage1-vs-Stage2 |
4.438600E-01 |
| Stage1-vs-Stage3 |
3.984200E-01 |
| Stage1-vs-Stage4 |
4.739400E-01 |
| Stage2-vs-Stage3 |
1.962780E-01 |
| Stage2-vs-Stage4 |
2.579400E-01 |
| Stage3-vs-Stage4 |
9.313200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.854200E-01 |
| Normal-vs-AfricanAmerican |
2.141200E-01 |
| Normal-vs-Asian |
6.036200E-01 |
| Caucasian-vs-AfricanAmerican |
1.469980E-01 |
| Caucasian-vs-Asian |
3.956200E-01 |
| AfricanAmerican-vs-Asian |
4.877800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.592200E-01 |
| Normal-vs-Female |
7.596400E-01 |
| Male-vs-Female |
4.375800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.810000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.978800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.864600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.337200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.572200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.462600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.635800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.531600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.089400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.060200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.221270E-03 |
| Classical-VS-Follicular |
9.900200E-01 |
| Classical-VS-Other |
2.374600E-01 |
| Classical-VS-Normal |
5.470000E-01 |
| Tall-VS-Follicular |
9.063300E-03 |
| Tall-VS-Other |
8.903200E-01 |
| Tall-VS-Normal |
3.434500E-02 |
| Follicular-VS-Other |
3.241400E-01 |
| Follicular-VS-Normal |
5.957200E-01 |
| Other-VS-Normal |
2.902000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.946200E-01 |
| Normal-vs-N1 |
4.198300E-02 |
| N0-vs-N1 |
1.140180E-02 |
|
|
